Inventor · disambiguated record
Tuyen Nguyen
Also filed as: NGUYEN TUYEN · NGUYEN TUYEN M
2 granted patents·10 pending applications·7 citations·filing 2012–2024
58Inventor score
Top patents by PatentIndex Score
12 records- 0187US9970006B2Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genesALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·4 cites·15 claims
- 0286US2024110180A1Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genesALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0380US9315813B2Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genesBETTENCOURT BRIAN·Filed 2012·Granted Apr 19, 2016·3 cites·17 claims
- 0477US2022049253A1Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0576US2020263176A1Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) GenesALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0675US2025115911A1Snca-targeting sirna compositions for treating snca-associated diseaseALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0774US2025059541A1Snca-targeting sirna compositions for treating snca-associated diseaseALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0866US2024240182A1HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0966US2024124882A1Prion protein (prnp) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1064US2018362978A1Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) GenesALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1161US2024301418A1iRNA Compositions and Methods for Silencing Filamin A (FLNA)ALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1255US2024301426A1Leucine-rich repeat kinase 2 (lrrk2) irna agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tuyen Nguyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →